{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:07:47Z","timestamp":1790194067323,"version":"4.1.0"},"reference-count":63,"publisher":"American Chemical Society (ACS)","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2022\/001158"],"award-info":[{"award-number":["CRG\/2022\/001158"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["EEQ\/2022\/000071"],"award-info":[{"award-number":["EEQ\/2022\/000071"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Herein, we report the first examples of ROS-responsive fluorogenic prodrugs that enable sustained intracellular delivery of celecoxib with a fluorescence turn-on readout and exhibit selective anticancer activity with reduced cardiotoxicity. Spectroscopic and HPLC analysis confirmed efficient ROS-mediated activation and time-dependent release of both celecoxib and the fluorophore, providing mechanistic insights into the stimuli-triggered prodrug activation and the self-immolative drug release profile under physiological conditions. The lead prodrug Cou-Coxib exhibited selective anticancer activity in triple-negative breast cancer (MDA-MB-231) cells over non-malignant cells and showed excellent therapeutic efficacy by S phase arrest. Furthermore, Cou-Coxib ameliorated celecoxib-induced cardiotoxicity in H9C2 cardiomyoblasts. The fluorogenic drug delivery process was validated with turn-on fluorescence readout in aqueous and cellular media and subsequently in developing zebrafish embryos. Overall, this study underscores the rational design of fluorogenic prodrugs of celecoxib exhibiting selective anticancer activity in breast cancer with attenuated cardiotoxicity, thereby offering improved therapeutic potential.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.6c01231","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:01:42Z","timestamp":1789149702000},"source":"Crossref","is-referenced-by-count":0,"title":["Strategic Development of Activatable Turn-On Fluorogenic Prodrugs of Celecoxib with Selective Anticancer Activity and Attenuated Cardiotoxicity"],"prefix":"10.1021","author":[{"given":"Roopjyoti","family":"Misra","sequence":"first","affiliation":[{"name":"Indian Institute of Technology Guwahati , , , ,","place":["Guwahati, Assam, India, 781039"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pallavi","family":"Barman","sequence":"additional","affiliation":[{"name":"Indian Institute of Technology Guwahati , , , ,","place":["Guwahati, Assam, India, 781039"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Das","sequence":"additional","affiliation":[{"name":"Institute of Advanced Study in Science and Technology (IASST) , , Vigyan Path , , ,","place":["Guwahati, Assam, India, 781035"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2148-2331","authenticated-orcid":true,"given":"Asis","family":"Bala","sequence":"additional","affiliation":[{"name":"Institute of Advanced Study in Science and Technology (IASST) , , Vigyan Path , , ,","place":["Guwahati, Assam, India, 781035"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9115-7561","authenticated-orcid":true,"given":"Krishna P.","family":"Bhabak","sequence":"additional","affiliation":[{"name":"Indian Institute of Technology Guwahati , , , ,","place":["Guwahati, Assam, India, 781039"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"2026091114013663400_cit1","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1039\/d5md00196j","article-title":"Recent advances in targeting COX-2 for cancer therapy: a review","volume":"16","author":"Kassab","year":"2025","journal-title":"RSC Med. Chem."},{"issue":"5","key":"2026091114013663400_cit2","doi-asserted-by":"publisher","first-page":"5683","DOI":"10.1002\/jcp.27411","article-title":"Cyclooxygenase-2 in cancer: a review","volume":"234","author":"Hashemi Goradel","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"11","key":"2026091114013663400_cit3","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1021\/ar100059g","article-title":"Functional Mimics of Glutathione Peroxidase: Bioinspired Synthetic Antioxidants","volume":"43","author":"Bhabak","year":"2010","journal-title":"Acc. Chem. Res."},{"issue":"7","key":"2026091114013663400_cit4","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1021\/cr000426w","article-title":"Chemistry of biologically important synthetic organoselenium compounds","volume":"101","author":"Mugesh","year":"2001","journal-title":"Chem. Rev."},{"issue":"5","key":"2026091114013663400_cit5","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1039\/A908114c","article-title":"Synthetic organoselenium compounds as antioxidants: glutathione peroxidase activity","volume":"29","author":"Mugesh","year":"2000","journal-title":"Chem. Soc. Rev."},{"issue":"35","key":"2026091114013663400_cit6","doi-asserted-by":"publisher","first-page":"10074","DOI":"10.1002\/anie.201505056","article-title":"Small Organoselenium Compounds: More than just Glutathione Peroxidase Mimics","volume":"54","author":"Wirth","year":"2015","journal-title":"Angew. Chem., Int. Ed."},{"issue":"8","key":"2026091114013663400_cit7","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1016\/j.bmc.2012.02.049","article-title":"Selenium-containing naphthalimides as anticancer agents: Design, synthesis and bioactivity","volume":"20","author":"Zhao","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"19","key":"2026091114013663400_cit8","doi-asserted-by":"publisher","first-page":"17350","DOI":"10.1021\/acs.jmedchem.4c01254","article-title":"A Highly Atom-Efficient Prodrug Approach to Generate Synergy between H2S and Nonsteroidal Anti-inflammatory Drugs and Improve Safety","volume":"67","author":"Peng","year":"2024","journal-title":"J. Med. Chem."},{"issue":"9","key":"2026091114013663400_cit9","doi-asserted-by":"publisher","first-page":"4966","DOI":"10.3390\/ijms22094966","article-title":"Novel Seleno-Aspirinyl Compound AS-10 Induces Apoptosis, G1 Arrest of Pancreatic Ductal Adenocarcinoma Cells, Inhibits Their NF-?B Signaling, and Synergizes with Gemcitabine Cytotoxicity","volume":"22","author":"Karelia","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"2026091114013663400_cit10","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1021\/acs.jmedchem.5b01503","article-title":"Design, Synthesis, and Biological Evaluation of Novel Selenium (Se-NSAID) Molecules as Anticancer Agents","volume":"59","author":"Plano","year":"2016","journal-title":"J. Med. Chem."},{"key":"2026091114013663400_cit11","doi-asserted-by":"publisher","first-page":"114839","DOI":"10.1016\/j.ejmech.2022.114839","article-title":"Design, synthesis and anticancer evaluation of novel Se-NSAID hybrid molecules: Identification of a Se-indomethacin analog as a potential therapeutic for breast cancer","volume":"244","author":"Ramos-Inza","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"22","key":"2026091114013663400_cit12","doi-asserted-by":"publisher","first-page":"16380","DOI":"10.1021\/acs.jmedchem.1c01460","article-title":"NSAIDs: Old Acquaintance in the Pipeline for Cancer Treatment and Prevention\u2212Structural Modulation, Mechanisms of Action, and Bright Future","volume":"64","author":"Ramos-Inza","year":"2021","journal-title":"J. Med. Chem."},{"issue":"9","key":"2026091114013663400_cit13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/13543776.2024.2373771","article-title":"Selective COX-2 inhibitors as anticancer agents: a patent review (2018-2023)","volume":"34","author":"Mahboubi-Rabbani","year":"2024","journal-title":"Expert Opin. Ther. Pat."},{"issue":"4","key":"2026091114013663400_cit14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1054\/mehy.1998.0009","article-title":"Genetic induction and upregulation of cyclooxygenase (COX) and aromatase (CYP19): an extension of the dietary fat hypothesis of breast cancer","volume":"52","author":"Harris","year":"1999","journal-title":"Med. Hypotheses"},{"issue":"7","key":"2026091114013663400_cit15","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1053\/gast.2002.33580","article-title":"Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus","volume":"122","author":"Buskens","year":"2002","journal-title":"Gastroenterology"},{"issue":"1","key":"2026091114013663400_cit16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3892\/or.6.1.71","article-title":"Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer","volume":"6","author":"Harris","year":"1999","journal-title":"Oncol. Rep."},{"key":"2026091114013663400_cit17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1097\/00001648-199603000-00017","article-title":"Nonsteroidal Antiinflammatory Drugs and Breast Cancer","volume":"7","author":"Harris","year":"1996","journal-title":"Epidemiology"},{"key":"2026091114013663400_cit18","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/1-4020-5688-5_9","article-title":"Cancer chemoprevention by cyclooxygenase 2 (COX-2) blockade: results of case control studies","volume":"42","author":"Harris","year":"2007","journal-title":"Subcell Biochem."},{"issue":"10","key":"2026091114013663400_cit19","doi-asserted-by":"publisher","first-page":"8555","DOI":"10.1021\/acsami.8b00875","article-title":"Celecoxib-induced self-assembly of smart albumin-doxorubicin conjugate for enhanced cancer therapy","volume":"10","author":"Shi","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"1","key":"2026091114013663400_cit20","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1038\/s41598-018-23439-7","article-title":"Voriconazole-induced photocarcinogenesis is promoted by aryl hydrocarbon receptor-dependent COX-2 upregulation","volume":"8","author":"Ikeya","year":"2018","journal-title":"Sci. Rep."},{"issue":"8","key":"2026091114013663400_cit21","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1007\/s00520-018-4096-2","article-title":"Text mining-based in silico drug discovery in oral mucositis caused by high-dose cancer therapy","volume":"26","author":"Kirk","year":"2018","journal-title":"Support Care Cancer"},{"key":"2026091114013663400_cit22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.canlet.2017.04.025","article-title":"The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer","volume":"400","author":"Brizzolara","year":"2017","journal-title":"Cancer Lett."},{"issue":"2","key":"2026091114013663400_cit23","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1177\/039463200601900217","article-title":"COX-inhibitors relieve the immunosuppressive effect of tumor cells and improve functions of immune effectors","volume":"19","author":"Lang","year":"2006","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"17","key":"2026091114013663400_cit24","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1056\/nejmp048286","article-title":"Failing the public health\ue5f8rofecoxib, Merck, and the FDA","volume":"351","author":"Topol","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"2026091114013663400_cit25","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1001\/archderm.143.6.711","article-title":"Cutaneous adverse reactions to valdecoxib distinct from Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"143","author":"Ziemer","year":"2007","journal-title":"Arch. Dermatol."},{"key":"2026091114013663400_cit26","first-page":"127","volume-title":"Specific COX-2 Inhibitors: From Bench to Bedside","author":"Isakson","year":"1998"},{"issue":"4","key":"2026091114013663400_cit27","doi-asserted-by":"publisher","first-page":"R422","DOI":"10.1186\/bcr1019","article-title":"Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells","volume":"7","author":"Basu","year":"2005","journal-title":"Breast Cancer Res."},{"issue":"1","key":"2026091114013663400_cit28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/1475-2867-12-53","article-title":"Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in vitro and in vivo","volume":"12","author":"Dai","year":"2012","journal-title":"Cancer Cell Int."},{"issue":"11","key":"2026091114013663400_cit29","doi-asserted-by":"publisher","first-page":"3116","DOI":"10.1194\/jlr.m042283","article-title":"Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib","volume":"54","author":"Ramer","year":"2013","journal-title":"J. Lipid Res."},{"issue":"2","key":"2026091114013663400_cit30","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3892\/ijo.2017.4227","article-title":"Cyclooxygenase-2 expression is induced by celecoxib treatment in lung cancer cells and is transferred to neighbor cells via exosomes","volume":"52","author":"Kim","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"5","key":"2026091114013663400_cit31","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1158\/1078-0432.ccr-04-1877","article-title":"Celecoxib inhibits prostate cancer growth: evidence of a cyclooxygenase-2-independent mechanism","volume":"11","author":"Patel","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"2026091114013663400_cit32","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1161\/01.CIR.0000160005.90598.41","article-title":"The use of nonsteroidal anti-inflammatory drugs (NSAIDs) a science advisory from the American Heart Association","volume":"111","author":"Bennett","year":"2005","journal-title":"Circulation"},{"issue":"12","key":"2026091114013663400_cit33","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1161\/circulationaha.106.181424","article-title":"Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association","volume":"115","author":"Antman","year":"2007","journal-title":"Circulation"},{"issue":"132","key":"2026091114013663400_cit34","doi-asserted-by":"publisher","first-page":"132ra54","DOI":"10.1126\/scitranslmed.3003787","article-title":"Vascular COX-2 modulates blood pressure and thrombosis in mice","volume":"4","author":"Yu","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"16","key":"2026091114013663400_cit35","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1161\/circulationaha.108.764530","article-title":"Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis","volume":"117","author":"Solomon","year":"2008","journal-title":"Circulation"},{"issue":"1","key":"2026091114013663400_cit36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1590\/1414-431x20133028","article-title":"Cellular and molecular studies of the effects of a selective COX-2 inhibitor celecoxib in the cardiac cell line H9c2 and their correlation with death mechanisms","volume":"47","author":"Sakane","year":"2013","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"8","key":"2026091114013663400_cit37","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1002\/art.23929","article-title":"Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs: An American College of Rheumatology white paper","volume":"59","author":"American College of Rheumatology Ad Hoc Group on Use of Selective and Nonselective Nonsteroidal Antiinflammatory Drugs","year":"2008","journal-title":"Arthritis Care Res."},{"issue":"6","key":"2026091114013663400_cit38","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00296-011-2263-6","article-title":"A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity","volume":"32","author":"Conaghan","year":"2012","journal-title":"Rheumatol. Int."},{"issue":"11","key":"2026091114013663400_cit39","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.3390\/pharmaceutics12111043","article-title":"Preparation and Evaluation of Amino Acid Conjugates of Celecoxib as Prodrugs to Improve the Pharmacokinetic and Therapeutic Properties of Celecoxib","volume":"12","author":"Lee","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1","key":"2026091114013663400_cit40","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12964-023-01398-5","article-title":"Interplay of oxidative stress, cellular communication and signaling pathways in cancer","volume":"22","author":"Iqbal","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"2026091114013663400_cit41","doi-asserted-by":"publisher","first-page":"9196","DOI":"10.1021\/acs.jmedchem.5c03627","article-title":"Targeting Highly Reactive Oxygen Species (hROS) for Prodrug Activation through a Cascade Reaction with Kinetic Tunability (CReKT) to Effect Linker Cleavage","volume":"69","author":"Kondengadan","year":"2026","journal-title":"J. Med. Chem."},{"issue":"17","key":"2026091114013663400_cit42","doi-asserted-by":"publisher","first-page":"4248","DOI":"10.1039\/D3TB02552G","article-title":"Inflammatory-stimuli-responsive turn-on NIR fluorogenic theranostic prodrug: adjuvant delivery of diclofenac and hydrogen sulfide attenuates acute inflammatory disorders","volume":"12","author":"Sufian","year":"2024","journal-title":"J. Mater. Chem. B"},{"issue":"59","key":"2026091114013663400_cit43","doi-asserted-by":"publisher","first-page":"8583","DOI":"10.1039\/C9CC04060A","article-title":"A nitroxyl-responsive near-infrared fluorescent chemosensor for visualizing H2S\/NO crosstalk in biological systems","volume":"55","author":"Yang","year":"2019","journal-title":"Chem. Commun."},{"key":"2026091114013663400_cit44","doi-asserted-by":"publisher","first-page":"107560","DOI":"10.1016\/j.bioorg.2024.107560","article-title":"Amonafide-based H2O2-responsive theranostic prodrugs: Exploring the correlation between H2O2 level and anticancer efficacy","volume":"150","author":"Yao","year":"2024","journal-title":"Bioorg. Chem."},{"key":"2026091114013663400_cit45","doi-asserted-by":"publisher","first-page":"480","DOI":"10.3389\/fonc.2019.00480","article-title":"Breast Cancer Subtypes Present a Differential Production of Reactive Oxygen Species (ROS) and Susceptibility to Antioxidant Treatment","volume":"9","author":"Sarmiento-Salinas","year":"2019","journal-title":"Front. Oncol."},{"issue":"2","key":"2026091114013663400_cit46","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1517\/14728222.2014.860447","article-title":"Expression of Cox-2 in human breast cancer cells as a critical determinant of epithelial-to-mesenchymal transition and invasiveness","volume":"18","author":"Bocca","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1","key":"2026091114013663400_cit47","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1039\/d5dt01997d","article-title":"A mitochondria-targeted green light-activatable binuclear ruthenium(ii) dithiocarbamate complex for synergistic type I\/II photodynamic therapy","volume":"55","author":"Negi","year":"2026","journal-title":"Dalton Trans."},{"issue":"7","key":"2026091114013663400_cit48","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.3390\/ijms22073622","article-title":"High ROS Production by Celecoxib and Enhanced Sensitivity for Death Ligand-Induced Apoptosis in Cutaneous SCC Cell Lines","volume":"22","author":"Zhu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"15","key":"2026091114013663400_cit49","doi-asserted-by":"publisher","first-page":"6376","DOI":"10.1039\/D5SC00156K","article-title":"Near-infrared light-activatable iridium(iii) complexes for synergistic photodynamic and photochemotherapy","volume":"16","author":"Negi","year":"2025","journal-title":"Chem. Sci."},{"issue":"19","key":"2026091114013663400_cit50","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1039\/D4CC06624C","article-title":"Visible light-induced photoisomerization of indole\u2212oxindole constructs: molecular disassembly and ROS-mediated apoptosis","volume":"61","author":"Tyagi","year":"2025","journal-title":"Chem. Commun."},{"issue":"21","key":"2026091114013663400_cit51","doi-asserted-by":"publisher","first-page":"22366","DOI":"10.1021\/acs.jmedchem.5c01314","article-title":"Nitro-Substituted Benzylic Organochalcogenides as Anticancer Agents: Unravelling the Multifaceted Pathways to Combat Triple-Negative Breast Cancer","volume":"68","author":"Barman","year":"2025","journal-title":"J. Med. Chem."},{"issue":"22","key":"2026091114013663400_cit52","doi-asserted-by":"publisher","DOI":"10.1002\/cmdc.202400358","article-title":"Synthetic Benzylic Diselenides and Disulfides: Potential Anticancer Activities via Modulation of the ROS-Dependent Akt\/\u03b2-Catenin Signaling Pathway","volume":"19","author":"Barman","year":"2024","journal-title":"ChemMedChem"},{"issue":"12","key":"2026091114013663400_cit53","doi-asserted-by":"publisher","first-page":"11293","DOI":"10.1021\/acsabm.5c02154","article-title":"Organoselenocyanate-Conjugated NBDHEX Derivatives as Potent Anticancer Agents for the Treatment of Breast Cancer via ROS-Regulated Signaling Pathways","volume":"8","author":"Pal","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"issue":"1","key":"2026091114013663400_cit54","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1080\/13880209.2017.1299768","article-title":"Folic acid ameliorates celecoxib cardiotoxicity in a doxorubicin heart failure rat model","volume":"55","author":"Ahmad","year":"2017","journal-title":"Pharm. Biol."},{"issue":"1","key":"2026091114013663400_cit55","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.22934","article-title":"Celecoxib decreases mitochondrial complex IV activity and induces oxidative stress in isolated rat heart mitochondria: An analysis for its cardiotoxic adverse effect","volume":"36","author":"Atashbar","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"6","key":"2026091114013663400_cit56","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1021\/acschemneuro.9b00106","article-title":"a Selenium-Containing Compound, Exerts Neuroprotective Effect via Modulation of the Keap1\u2212Nrf2\u2212ARE Pathway and Attenuates A\u03b2-Induced Cognitive Impairment in Vivo","volume":"10","author":"Yan","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"2026091114013663400_cit57","doi-asserted-by":"publisher","first-page":"107475","DOI":"10.1016\/j.intimp.2021.107475","article-title":"The role of interleukin-10 family members in cardiovascular diseases","volume":"94","author":"Xu","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"17","key":"2026091114013663400_cit58","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.133050","article-title":"IL-10 provides cardioprotection in diabetic myocardial infarction via upregulation of Heme clearance pathways","volume":"5","author":"Gupta","year":"2020","journal-title":"JCI Insight"},{"issue":"7","key":"2026091114013663400_cit59","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1021\/acs.chemrestox.9b00152","article-title":"N-Acetylcysteine: Antioxidant, Aldehyde Scavenger, and More","volume":"32","author":"Zhitkovich","year":"2019","journal-title":"Chem. Res. Toxicol."},{"issue":"2","key":"2026091114013663400_cit60","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1021\/acs.jmedchem.6b01911","article-title":"Protein degradation via CRL4CRBN ubiquitin ligase: discovery and structure\u2212activity relationships of novel glutarimide analogs that promote degradation of aiolos and\/or GSPT1","volume":"61","author":"Hansen","year":"2018","journal-title":"J. Med. Chem."},{"issue":"8","key":"2026091114013663400_cit61","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1021\/acs.jmedchem.7b01775","article-title":"Synthesis and Evaluation of Hydrogen Peroxide Sensitive Prodrugs of Methotrexate and Aminopterin for the Treatment of Rheumatoid Arthritis","volume":"61","author":"Peiro\u0301 Cadahi\u0301a","year":"2018","journal-title":"J. Med. Chem."},{"key":"2026091114013663400_cit62","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1039\/D1TB02425F","article-title":"Thioredoxin reductase-triggered fluorogenic donor of hydrogen sulfide: a model study with a symmetrical organopolysulfide probe with turn-on near-infrared fluorescent emission","volume":"10","author":"Mahato","year":"2022","journal-title":"J. Mater. Chem. B"},{"key":"2026091114013663400_cit63","doi-asserted-by":"publisher","first-page":"104809","DOI":"10.1016\/j.fbio.2024.104809","article-title":"Candy leaf - Stevia rebaudiana (Bertoni) Bertoni attenuated LPS-induced protein kinase C phosphorylation in mouse macrophages cells: Target search by network pharmacology and validation using ex vivo and in vivo assays","volume":"61","author":"Devroy","year":"2024","journal-title":"Food Biosci."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.6c01231","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/doi\/10.1021\/acs.jmedchem.6c01231\/68488517\/jm6c01231.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/doi\/10.1021\/acs.jmedchem.6c01231\/68488517\/jm6c01231.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:43:25Z","timestamp":1790192605000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/doi\/10.1021\/acs.jmedchem.6c01231\/5428686\/Strategic-Development-of-Activatable-Turn-On"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":63,"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.6c01231","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]}}}